Authors
Latest:
Opioid Use Disorder Treatment Inconsistent Around United StatesAt the state level, medication treatment rates ranged from 17.7% in Kansas to 82.8% in Maine.
Latest:
AMD Risk Not Tied to Long-Term Metformin UseThe researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.
Latest:
New Drug Review: FDA Approves Tryvio for the Treatment of Hypertension in Combination With Other Antihypertensive Drugs to Lower Blood PressureTryvio was given FDA approval on March 19, 2024.
Latest:
Q&A: Insulin Cost Cap Linked to Better Treatment Persistence | PQA 2025Razanne Oueini, PharmD, MSc, CPHQ, discusses how rates of persistence to basal insulin were impacted after the IRA monthly cap.
Latest:
Mitigating Costs of Cancer Treatment: The Role of PharmacistsCancer care is expensive, but pharmacists can help.
Latest:
Anti-PD-1 Therapy for Melanoma Associated With Chronic Immune-Related Adverse EventsThe majority of persistent irAEs were hypothyroid, adrenal insufficiency, arthritis, dermatitis or pruritis, and hypophysitis.
Latest:
Vitamin D and COVID-19: An Evidence-Based ReviewIn this article, we will review the evidence describing a possible link between vitamin D and COVID-19.
Latest:
Maximum (Un)Fair PriceHow pharmacies will pay for the Medicare Drug Price Negotiation Program
Latest:
A Review of FDA-Approved Medications for Chronic Weight ManagementFive medications are currently approved by the FDA for chronic weight management.
Latest:
The Ever-Expanding Role of Consultant Pharmacists in Long-term CareClinical consultant pharmacists offer an individualized approach to the needs of long-term care facilities.
Latest:
Melphalan Flufenamide for Relapsed or Refractory Multiple MyelomaMelphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
Latest:
Coming out of COVID: 5 Objectives for Boosting Rx Business and Cash Clinical ServicesOllin Sykes, CPA, CITP, and Scotty Sykes, CPA, CFP, discuss the business landscape after COVID within pharmacies and 5 objectives for focusing on growth again.
Latest:
Practice Update: Treating Patients Hospitalized With COVID-19Several institutions have published guidance on how to treat patients hospitalized with COVID-19.
Latest:
Review of FDA Approvals for Pediatric Obesity ManagementGLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
Latest:
Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.
Latest:
Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy SettingPharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations.
Latest:
Detecting Crossover Symptoms of COVID-19, InfluenzaAs respiratory viruses and COVID-19 variants lurk seemingly everywhere, here’s how best to detect and differentiate.
Latest:
The Health Care Professional’s Role in Creating Equitable Patient OutcomesAn essay by Lord Simon Woolley that was published in BMJ calls on the medical community to speak up on how failed drug laws disproportionately harm black communities.
Latest:
Current and Future Treatments for Hidradenitis SuppurativaHidradenitis suppurativa is a chronic inflammatory skin condition that presents with painful, deep, and inflamed lesions found in flexural, apocrine gland-bearing sites.
Latest:
Pilot Program From Custom Health, L.A. Care, Tackles Medication AdherenceCustom is one of the growing number of companies focusing on adherence. It changed its name from Pack4U last year.
Latest:
Using Data to Put a Stop to Your Pharmacy's Profit LeakageTechnology will help you identify potential reimbursement problems before they trigger reduced payments or claims audits.
Latest:
FDA Accepts GSK's BLA for 5-in-1 Meningococcal VaccineThe company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
Latest:
Challenges of Drug Diversion in Health Care Settings Amid High Staff Turnover, Budget CutsWith the risk of diversion potentially greater than it was before the pandemic, these data should be viewed as a warning sign.
Latest:
Chewable Tablet Receives FDA Approval for Internal and External Parasites in DogsAfoxolaner, moxidectin, and pyrantel chewable tablets protect dogs from fleas, ticks, heartworm disease, roundworms, and hookworms.
Latest:
A Partnership to Optimize Medication Use and Patient OutcomesInitiative promotes adoption of value-based care models in community pharmacy settings.
Latest:
Sustaining Positivity Among Students, Professionals Critical for Pharmacy’s FutureA conversation with David Nau, PhD, professor of social and administrative pharmacy, and director of assessment at Ohio Northern University.
Latest:
COVID-19 Vaccines: A Focus on SafetyEase patients’ concerns by being well versed in the safety profiles of each vaccine.
Latest:
FDA Sets Review Date for Chronic Lung Disease Therapy BrensocatibFirst-in-class brensocatib has the potential to be the first approved treatment for bronchiectasis.
